Mon Dec 02 11:23:14 UTC 2024: ## Suraksha Diagnostic IPO Receives Tepid Response, Closes Undersubscribed
**Mumbai, December 3, 2024** – The initial public offering (IPO) of Suraksha Diagnostic Limited concluded today with a lukewarm reception from investors. The ₹846.25 crore IPO, which opened on November 29th, failed to generate significant interest, closing significantly undersubscribed. Retail investor participation reached only 20% of their allocation.
The IPO, entirely an Offer for Sale (OFS), saw a subscription rate of just 0.11 times by the end of the first day. This means that only a small fraction of the offered shares were applied for. Further dampening investor enthusiasm, the grey market premium (GMP) remained at zero throughout the offering period, suggesting no expected premium or discount on listing at the upper price band of ₹441.
Suraksha Diagnostic, established in 2005, provides a range of healthcare services including pathology, radiology, and medical consultations, operating through a network of labs and customer touchpoints. However, the company will not receive any proceeds from the IPO as the entire offering was an OFS, benefiting only existing shareholders.
Financial analysts suggest potential investors should carefully consider the risks before investing in Suraksha Diagnostic, given the low subscription rate, neutral GMP, and lack of direct benefit to the company from the raised capital.
First Piper 